From cancer to rare diseases, Big Pharma puts profit before patients when deciding on new drugs

Instead of focusing on which illnesses are most in need of treatments or cures, too often drug firms base their decisions on money, explains award-winning investigative reporter Billy Kenber, author of ‘Sick Money’
— Read on

Leave a Comment

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s